Medium
About Respiratory Illness Vaccines
Medium
h2
Left
About Respiratory Illness Vaccines
COVID-19 Vaccine
- Options: Updated as needed to match dominant strain (Pfizer mRNA, Moderna mRNA, Novavax)
- Eligibility:
- Effectiveness: Reduces risk of severe illness by 30-60%
- When to get: Available any time, discuss timing with your provider
RSV Vaccine (Pregnancy)
- Options: Pfizer
- Eligibility: Pregnant people who have not received a dose during a previous pregnancy (protection will pass to baby for first 6 months of life) (AAFP) (ACOG) (CDC)
- Effectiveness: Reduces risk of severe illness in first 3 months of life by 82%
- When to get: September-January, during 32-36 weeks gestation
RSV Antibody (Infants)
- Options: Nirsevimab (Sanofi) or Clesrovimab (Merk)
- Eligibility:
- Effectiveness: 80-96% effective against hospitalization
- When to get: October - March
Medium

Medium
Medium
Medium